CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain‐Barré syndrome
Authors:
- A. PetzoldAPA. Petzold
- N.M.F. MurrayNMN.M.F. Murray
- N.P. HirschNHN.P. Hirsch
- M.M. ReillyMRM.M. Reilly
- 16 June 2009
- journal article
- clinical trial
- Published by Wiley in Muscle & Nerve
- Vol. 40 (1) , 42-49
Abstract
Early predictors of prognosis in Guillain‐Barré syndrome (GBS) are needed to identify patients who are likely to make a poor recovery and to guide therapeutic decision‐making in the acute phase. Here we investigate whether axonal protein biomarkers released into the cerebrospinal fluid (CSF) following proximal axonal damage improve the early prognostic accuracy in GBS. A prospective multicenter study including 132 patients (38 GBS, 38 neurological controls, 42 headaches, 14 chronic inflammatory demyelinating neuropathy). CSF levels of axonal [neurofilament (NfH) and tau] and glial (S100B and glial fibrillary acidic protein) protein biomarkers were measured on admission. Nerve conduction studies were performed at the time of lumbar puncture and patients were classified according to neurophysiological criteria. Outcome was assessed on the Hughes functional score (F‐score). Poor outcome was defined as the inability to walk independently (F‐score ≥3). High NfH levels (>0.73 ng/ml) predicted poor outcome (P = 0.01) with an odds ratio of 7.3 and correlated with the outcome F‐score (R = 0.51, P < 0.01), as did hTau levels (R = 0.47, P < 0.01). Patients with poor outcome had significantly higher CSF NfH (median 1.78 ng/ml) when compared to those with good outcome (0.03 ng/ml) or all of the control groups (neurological controls 0.18 ng/ml, headaches 0.06 ng/ml, chronic inflammatory demyelinating neuropathy 0.05 ng/ml). Except for age (P < 0.05) and need for ventilatory support (P < 0.05), none of the other features reliably predicted outcome. Improved prognostic accuracy in the acute phase of GBS seems possible using CSF NfH levels. Muscle Nerve 40: 42–49, 2009Keywords
This publication has 20 references indexed in Scilit:
- Simple scoring system to predict outcome in Guillain–Barré syndromeNature Clinical Practice Neurology, 2007
- Early prediction of prognosis in Guillain–Barré syndromeThe Lancet Neurology, 2007
- CSF tau protein: A new prognostic marker for Guillain-Barré syndromeNeurology, 2006
- CSF neurofilament levels: A potential prognostic marker in Guillain–Barré syndromeNeurology, 2006
- European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve SocietyEuropean Journal of Neurology, 2006
- An ELISA for glial fibrillary acidic proteinJournal of Immunological Methods, 2004
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD InitiativeRadiology, 2003
- Pre-existing pathways promote precise projection patternsNature Neuroscience, 2002
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990